A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia.
Author | |
---|---|
Abstract | :
Iron deficiency anaemia is common in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) and is often treated with oral or intravenous (IV) iron therapy. This trial compared the efficacy and safety of IV iron isomaltoside 1000 (MonoferĀ®) and oral iron in NDD-CKD patients with renal-related anaemia. |
Year of Publication | :
2016
|
Journal | :
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
|
Volume | :
31
|
Issue | :
4
|
Number of Pages | :
646-55
|
ISSN Number | :
0931-0509
|
URL | :
https://academic.oup.com/ndt/article-lookup/doi/10.1093/ndt/gfv293
|
DOI | :
10.1093/ndt/gfv293
|
Short Title | :
Nephrol Dial Transplant
|
Download citation |